Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Friday, August 22, 2014

Indication of considerable added benefit for ruxolitinib in myelofibrosis

Ruxolitinib has been approved since August 2012 for the treatment of adults with myelofibrosis.

http://ift.tt/YHnfma

No comments:

Post a Comment

Popular Stem Cell Roundup Posts